Iatros GmbH, with its well established KOL network, is in a position to carry out a due diligence process and lead through all the steps needed to thoroughly assess a strategic project proposal, including its feasibility, innovativeness,  medical/scientific value, market potential and positioning, as well as competitiveness. This may involve several steps, including:

• the identification of the unmet clinical needs in relevant disease areas
• the assessment and validation of candidate genes as therapeutic targets 
• the evaluation of treatment options and patients stratification
• the selection of diagnostic partners in the development of CDx (pre- and clinical development)

We also offer expert advice for personalized IT solutions in clinical/technical validation studies and documentation for submission to competent authorities.